CHEGAEV, Konstantin

CHEGAEV, Konstantin  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 93 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
Aceclofenac-galactose conjugate: design, synthesis, characterization and pharmacological and toxicological evaluations 2018 Magliocca, Salvatore; De Caro, Carmen; Lazzarato, Loretta; Russo, Roberto; Rolando, Barbara; Chegaev, Konstantin; Marini, Elisabetta; Nieddu, Maria; Burrai, Lucia; Boatto, Gianpiero; Cristiano, Claudia; Marabello, Domenica; Gazzano, Elena; Riganti, Chiara; Sodano, Federica; Rimoli, Maria Grazia
Amphiphile NO-donor antioxidants as polivalent drugs 2006 MARINI E; LAZZARATO L; CHEGAEV K; FRUTTERO R; GASCO A
Amphiphilic NO-Donor Antioxidants 2007 K. CHEGAEV; L. LAZZARATO; B. ROLANDO; E. MARINI; G.V. LOPEZ; M. BERTINARIA; A. DI STILO; R. FRUTTERO; A. GASCO
A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors 2022 Alov P.; Al Sharif M.; Aluani D.; Chegaev K.; Dinic J.; Divac Rankov A.; Fernandes M.X.; Fusi F.; Garcia-Sosa A.T.; Juvonen R.; Kondeva-Burdina M.; Padron J.M.; Pajeva I.; Pencheva T.; Puerta A.; Raunio H.; Riganti C.; Tsakovska I.; Tzankova V.; Yordanov Y.; Saponara S.
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity 2017 Dos Santos Fernandes, Guilherme Felipe; De Souza, Paula Carolina; Moreno-viguri, Elsa; Santivaã±ez-veliz, Mery; Paucar, Rocio; Pã©rez-silanes, Silvia; Chegaev, Konstantin; Guglielmo, Stefano; Lazzarato, Loretta; Fruttero, Roberta; Man Chin, Chung; Da Silva, Patricia Bento; Chorilli, Marlus; Solcia, Mariana Cristina; Ribeiro, Camila Marã­ngolo; Silva, Caio Sander Paiva; Marino, Leonardo Biancolino; Bosquesi, Priscila Longhin; Hunt, Debbie M.; De Carvalho, Luiz Pedro S.; De Souza Costa, Carlos Alberto; Cho, Sang Hyun; Wang, Yuehong; Franzblau, Scott Gary; Pavan, Fernando Rogã©rio; Dos Santos, Jean Leandro
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 2004 C. CENA; D. BOSCHI; G.C. TRON; K. CHEGAEV; L. LAZZARATO; A. DI STILO; M. ARAGNO; R. FRUTTERO; A. GASCO
Direct introduction of cyano group on furoxan ring 2017 Annaratone, Lorenzo; Guglielmo, Stefano; Chegaev, Konstantin
Discovery of phenylsulfonylfuroxan derivatives as gamma globin inducers by histone acetylation 2018 Melo, Thais Regina Ferreira de; Kumkhaek, Chutima; Fernandes, Guilherme Felipe dos Santos; Lopes Pires, Maria Elisa; Chelucci, Rafael Consolin; Barbieri, Karina Pereira; Coelho, Fernanda; Capote, Ticiana Sidorenko de Oliveira; Lanaro, Carolina; Carlos, Iracilda Zeppone; Marcondes, Sisi; Chegaev, Konstantin; Guglielmo, Stefano; Fruttero, Roberta; Chung, Man Chin; Costa, Fernando Ferreira; Rodgers, Griffin P.; dos Santos, Jean Leandro*
Doxorubicin-antioxidant multitarget drugs 2013 K Chegaev; C Riganti; B Rolando; L Lazzarato; E Gazzano; S Guglielmo; D Ghigo; R Fruttero; A Gasco
Edaravone derivatives containing NO-donor functions 2009 Konstantin Chegaev; Clara Cena; Marta Giorgis; Barbara Rolando; Paolo Tosco; Massimo Bertinaria; Roberto Fruttero; Pier-Alain Carrupt; Alberto Gasco
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury 2009 Antonella Di Stilo; Konstantin Chegaev; Loretta Lazzarato; Roberta Fruttero; Alberto Gasco; Raffaella Rastaldo; Sandra Cappello
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma 2019 Buondonno, Ilaria; Gazzano, Elena; Tavanti, Elisa; Chegaev, Konstantin; Kopecka, Joanna; Fanelli, Marilù; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto; Hattinger, Claudia; Serra, Massimo; Riganti, Chiara*
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. 2015 Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S.
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 2018 Gazzano, Elena; Rolando, Barbara; Chegaev, Konstantin; Salaroglio, Iris C.; Kopecka, Joanna; Pedrini, Isabella; Saponara, Simona; Sorge, Matteo; Buondonno, Ilaria; Stella, Barbara; Marengo, Alessandro; Valoti, Massimo; Brancaccio, Mara; Fruttero, Roberta; Gasco, Alberto; Arpicco, Silvia; Riganti, Chiara
Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents 2014 Konstantin Chegaev; Loretta Lazzarato; Yasinalli Tamboli; Donatella Boschi; Marco Blangetti; Andrea Scozzafava; Fabrizio Carta; Emanuela Masini; Roberta Fruttero; Claudiu T. Supuran; Alberto Gasco
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis 2018 Di Guida, Francesca; Pirozzi, Claudio; Magliocca, Salvatore; Santoro, Anna; Lama, Adriano; Russo, Roberto; Nieddu, Maria; Burrai, Lucia; Boatto, Gianpiero; Mollica, Maria Pina; Sodano, Federica; Lazzarato, Loretta; Chegaev, Konstantin; Meli, Rosaria; Raso, Giuseppina Mattace*; Rimoli, Maria Grazia
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension 2017 Blangetti, Marco; Rolando, Barbara; Marini, Elisabetta; Chegaev, Konstantin; Guglielmo, Stefano; Lazzarato, Loretta; Laura, Lucarini; Emanuela, Masini; Fruttero, Roberta
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance 2016 Chegaev, Konstantin; Rolando, Barbara; Cortese, Daniela; Gazzano, Elena; Buondonno, Ilaria; Lazzarato, Loretta; Fanelli, Marilù; Hattinger, Claudia M; Serra, Massimo; Riganti, Chiara; Fruttero, Roberta; Ghigo, Dario; Gasco, Alberto
Highly diastereoselective synthesis of 2-monosubstituted 1R,5S(1S,5R)-glycoluriles on the basis of S- and R-N-carbamoyl-alpha-amino acids 2003 KRAVCHENKO A.N; K. CHEGAEV; CHIKUNOV I.E; BELYAKOV P.A; MAKSAREVA E.Y; LYSSENKO K.A; LEBEDEV O.V; MAKHOVA N.N
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 2019 Gazzano E.; Buondonno I.; Marengo A.; Rolando B.; Chegaev K.; Kopecka J.; Saponara S.; Sorge M.; Hattinger C.M.; Gasco A.; Fruttero R.; Brancaccio M.; Serra M.; Stella B.; Fattal E.; Arpicco S.; Riganti C.